| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |